Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

NCT01207128 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped None enrolled

Conditions

Aspergillosis

Interventions

DRUG: Voriconazole, micafungin

Sponsor

University of Arkansas